User talk:EndotoxinEd

A move has been proposed at Talk:Flourishglobal Peptide Biotech. Since you wrote most of the article's current text you may have a view on whether the proposed title is the one a reader would search for. — StubSorterBot (talk) 13:00, 28 September 2024 (UTC)

Commented. My own view is that the current title is the searchable one, but I hold it loosely. — EndotoxinEd (talk) 04:41, 30 September 2024 (UTC)

GL Biochem (Shanghai) was in Category:Peptide suppliers but not in its parent chain, so it was invisible from the topic portal. I have fixed it. If you are adding categories in bulk, Special:WantedPages lists the ones that are currently claimed by articles but have no page. — BlankVialBo (talk) 15:16, 5 October 2024 (UTC)

Thank you. I had been adding the leaf category without the parent, which explains why the portal listings looked so thin. — EndotoxinEd (talk) 20:46, 6 October 2024 (UTC)

We have now reverted each other twice on Flourishglobal Peptide Biotech, which is a sign that the disagreement is substantive rather than accidental. My reading is that the source supports the weaker of the two claims. Rather than continue in edit summaries, shall we put it on the article talk page and let someone else weigh in? — CapitalisationCaz (talk) 09:05, 18 November 2024 (UTC)

Agreed, and I would rather be argued out of it than keep reverting. I have opened a section. — EndotoxinEd (talk) 11:33, 18 November 2024 (UTC)

Welcome. Your work on Beyond-use date was a useful addition — it was one of the thinner pages in its topic area.

One convention to note for next time: numeric claims need an inline citation each, not one citation at the end of the paragraph, because the paragraph usually ends up split later and the citation then attaches to the wrong sentence. See Project:Sourcing guidelines. — ArchiveBot (talk) 04:20, 18 December 2024 (UTC)

There is a request for comment open on Talk:GL Biochem (Shanghai) that touches an area you have edited in. It concerns how strongly the article should state that human evidence is absent, and it would benefit from more than three voices. — CheckSumChase (talk) 05:58, 25 February 2025 (UTC)

Thank you for the pointer — I have commented. — EndotoxinEd (talk) 11:20, 26 February 2025 (UTC)

Given your edits around GL Biochem (Shanghai), you might find the working-group pages useful — Project:Analytical working group, Project:Pharmacology working group and Project:Clinical evidence working group each keep a short priority list, and the priorities are mostly things one person can finish in an afternoon. — Chromatokid (talk) 12:36, 25 October 2025 (UTC)

Thank you, the priority lists are genuinely more useful than a general backlog. — EndotoxinEd (talk) 16:56, 26 October 2025 (UTC)